Intravenous pulsed therapy with prednisolone hemisuccinate in severe forms of systemic lupus erythematosus
Solakov, P.; Atanasov, K.
Vutreshni Bolesti 27(5): 72-73
1988
ISSN/ISBN: 0506-2772 PMID: 3213042 Document Number: 323990
The intravenous pulsed treatment with prednisone hemisuccinate of severe forms of systemic lupus erythematosus influences favorably the basic clinical manifestations of the disease--polyarthritis, fever, vasculitis, myocarditis, sialoadenitis. Prednisolone is as efficient as methylprednisolone in the pulsed treatment of patients with systemic lupus erythematosus.
Document emailed within 1 workday
Related Documents
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222Yang, X.; Yin, P.; Gao, X. 1996: A study on interval of intravenous cyclophosphamide pulse in the treatment of severe systemic lupus erythematosus Zhonghua Nei Ke Za Zhi 35(4): 257-260
Hashkes, P.J.; Lovell, D.J. 1996: Vasculitis in systemic lupus erythematosus following intravenous immunoglobulin therapy Clinical and Experimental Rheumatology 14(6): 673-675
Vasiliu, I.M.; Petri, M.A.; Baer, A.N. 2006: Therapy with granulocyte colony-stimulating factor in systemic lupus erythematosus may be associated with severe flares Journal of Rheumatology 33(9): 1878-1880
Lin, W.S.; Yang, W.S.; Lin, H.Y. 1995: Prednisolone non-compliance and its related factors in patients with systemic lupus erythematosus Zhonghua Yi Xue Za Zhi 56(4): 244-251
Wysocka, K.; Kiczak, J.; Pozorska, D. 1977: Immunocoagulopathy (lupus anticoagulant) with severe hemorrhagic diathesis in systemic lupus erythematosus Wiadomosci Lekarskie 30(14): 1129-1134
Merola, J.F.; Chang, C.A.; Sanchez, M.R.; Prystowsky, S.D. 2011: Is chronic cutaneous discoid lupus protective against severe renal disease in patients with systemic lupus erythematosus? Journal of Drugs in Dermatology: Jdd 10(12): 1413-1420
Carr, R.; Forsyth, S.; Sadi, D. 1987: Abnormal responses to ingested substances in murine systemic lupus erythematosus: apparent effect of a casein-free diet on the development of systemic lupus erythematosus in NZB/W mice Journal of Rheumatology. Suppl 14(Suppl 13): 158-165
Varela Aguilar, J.M.; Sánchez Román, J.; Bravo-Ferrer, J. 1990: Severe infection in systemic lupus erythematosus Revista Clinica Espanola 186(2): 97-98
Anić, B.; Crkvencić, N.; Mayer, M.; Bosnić, D.; Sentić, M.; Markeljević, J.; Cikes, N. 1999: Intermittent intravenous cyclophosphamide application in patients with systemic lupus erythematosus Lijecnicki Vjesnik 121(9-10): 283-288
Maltbaek, N.; Harreby, M.S.; Thøgersen, B. 1994: Intravenous immunoglobulin administration to a patient with systemic lupus erythematosus and pneumococcal septicemia Ugeskrift for Laeger 156(27): 4039-4041
Tahara, K.; Nishiya, K.; Nishioka, T.; Yoshida, T.; Matsubara, Y.; Hashimoto, K. 1999: A case of systemic lupus erythematosus associated with severe acute pancreatitis Ryumachi 39(3): 598-603
Camara, I.; Sciascia, S.; Simoes, J.; Pazzola, G.; Salas, V.; Karim, Y.; Roccatello, D.; Cuadrado, M.J. 2014: Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre Clinical and Experimental Rheumatology 32(1): 41-47
Tarrant, T.K.; Frazer, D.H.; Aya-Ay, J.P.; Patel, D.D. 2003: B cell loss leading to remission in severe systemic lupus erythematosus Journal of Rheumatology 30(2): 412-414
Winder, A.; Molad, Y.; Ostfeld, I.; Kenet, G.; Pinkhas, J.; Sidi, Y. 1993: Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases Journal of Rheumatology 20(3): 495-498
Leung, F.K.; Fortin, P.R. 2003: Intravenous cyclophosphamide and high dose corticosteroids improve MRi lesions in demyelinating syndrome in systemic lupus erythematosus Journal of Rheumatology 30(8): 1871-1873
Nishina, M.; Saito, E.; Kinoshita, M. 1996: Dapsone (4,4'-diaminodiphenyl sulfone) resolved severe leukocytopenia and thrombocytopenia in a patient with systemic lupus erythematosus Ryumachi 36(5): 757-761
Spertini, F.ço. 2007: New concepts for the therapy of systemic lupus erythematosus Revue Medicale Suisse 3(94): 98-102
Taylor, J.K.; McMurray, R.V. 2011: Medical therapy for systemic lupus erythematosus Journal of the Mississippi State Medical Association 52(2): 39-43
Wang, Q.L.; Yin, J.N.; Han, Z.R. 1986: A case of fulminant systemic lupus erythematosus complicated by severe aspergillar septicemia confirmed by pathologic findings Chinese Medical Journal 99(6): 493-497